Conceivable Life Sciences developed the world's first AI-powered automated IVF laboratory to make fertility treatment more accessible, efficient, and successful. Through proprietary automation technology, AI, robotics, and advanced optics, the company is standardizing microscopic IVF procedures to enhance the precision and consistency required to transform a Nobel Prize-winning therapy from concierge medicine for the rich to a population health solution for anyone who needs it.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/16/25 | $50,000,000 | Series A |
ACME Advance Venture Partners  Artis Ventures Stride | undisclosed |
